Panel: Access is the real innovation: How Europe turns breakthroughs into therapies patients can actually receive

Understanding the AGORA model:
How collaborative, hospital-anchored models like AGORA are reshaping access to gene and cell therapies for rare and ultra-rare diseases.

We cannot scale without hospitals: How developers and health systems must rethink roles, incentives, and workflows to make access viable and sustainable.

Delivery through partnership, not heroics: Which partnership models are most likely to work in Europe and why no single stakeholder can solve access alone.

Confronting the economics honestly: The real financial and operational constraints behind expanding access to advanced therapies and how teams are navigating them without diluting innovation.